CVRX, INC. (CVRX) Announces Regulatory Update
CVRX, INC. (CVRX) provided an update on regulatory developments for its product portfolio.
Regulatory Update Details:
• Regulatory Agencies: FDA (U.S. Food and Drug Administration)
• Status: Approved
Clinical Development:
🔬 Clinical Development Pipeline (CVRX, INC.):
Product
Type
Development Stage
Therapeutic Area
Source
Barostim™ System
Other
Preclinical
Heart Failure
ClinicalTrials.gov
Usual care medical management
Other
Approved
Heart Failure
ClinicalTrials.gov
Barostim System
Other
Approved
Heart Failure
ClinicalTrials.gov
Baroreflex Activation Therapy
Drug
Approved
HFrEF - Heart Failure With Reduced Ejection Fraction
ClinicalTrials.gov
Medical Management
Other
Approved
Heart Failure
ClinicalTrials.gov
BAROSTIM NEO System
Other
Approved
Heart Failure
ClinicalTrials.gov
BATwire Implant Kit
Other
Approved
Heart Failure
ClinicalTrials.gov
Standard of care medical managment therapy for heart failure
📋 CVRX, INC. (CVRX) - Regulatory Update
Filing Date: 2026-08-11
Accepted: 2026-08-11 07:09:16
Event Type: Regulatory Update
Event Details:
🔬 Clinical Development Pipeline (CVRX, INC.):
💼 Business Developments:
Structured Data: